Yale Cancer Center and our partner, Smilow Cancer Hospital, acknowledge the seven American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) evidence-based quality guidelines for breast and colorectal cancers.  The latest performance data for colorectal cancer is listed below.

Colorectal Measures Expected Estimated Performance Rates (percentage) Yale Performance 2012 Yale Performance 2013 Yale Performance 2014
Adjuvant chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer (Accountability) 90% 95.00 100.00 90.60

**Higher percentage is better